Industry News
Medical Device Industry News

WuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUI™ in 2,000L GMP Manufacturing
By leveraging its ultra-intensified fed-batch platform, WuXiUI™, WuXi Biologics has completed its first scale-up to 2,000L drug substance (DS) GMP manufacturing, achieving a 4-fold productivity improvement compared to the traditional fed-batch process. The competitive performance
Advancing Fully Implanted Hearing Systems | By Brent Lucas, CEO of Envoy Medical
Envoy Medical has taken a different approach with its fully implanted hearing devices, and it looks to turn the industry on its… ear. "Listen" to what Brent Lucas, CEO of the company has to say.
Anavex Tackles Cognitive Aging and Related Disease Pathologies
Anavex Life Sciences focuses on better understanding cognitive aging, superagers and how disease pathologies relate to cognitive aging.
Kidney Donors | Risk of Death at All-Time Low
The results further showed that while their overall risk remained small, kidney donors who were male and those with a history of high blood pressure were more likely to die within 90 days of surgery
Abhisek Swaika, MD to Lead Northwell Cancer Institute at Rego Park
“Dr. Abhisek Swaika is deeply committed to ensuring the delivery of the highest quality, state-of-the art cancer care,” said Richard Carvajal, MD, deputy physician-in-chief and director of medical oncology at Northwell Health Cancer Institute. “His
Delcath Systems Reports Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients
The 30-patient study reported that the Delcath Systems HEPZATO KIT™ (melphalan/Hepatic Delivery System (HDS)) provided better disease control in the liver and improved progression-free survival in patients with hepatic metastases from uveal melanoma, compared to
PaceMate Acquires Medtronic Paceart Optima™ System, Bringing Complementary Capabilities to Cardiac Data Management
“After a comprehensive evaluation, we are confident PaceMate is the best organization to service Paceart customers and their future cardiac data workflow needs,” said Kweli P. Thompson, M.D., M.P.H., senior vice president and president, Medtronic
FDA Approves Illumina Cancer Biomarker Test with 2 Companion Diagnostics to Rapidly Match Patients to Targeted Therapies
"FDA approval for TruSight Oncology Comprehensive with accompanying companion diagnostics marks an awaited milestone for our oncology customers and community," said Everett Cunningham, chief commercial officer of Illumina. "We are committed to partnering with industry
Accuray Receives CE Mark for a New Helical Radiation Delivery System, Accuray Helix
Accuray Helix delivers precise, targeted radiation treatments, an important option for the routine cases clinical teams see daily in their practice including breast, cervix, head and neck, gastrointestinal, lung, and prostate.
ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse
EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.
Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System
The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with
Why You Should Visit Small Coffee Shops Like Little Lingonberry in Palm Beach Gardens, FL
In Palm Beach Gardens, FL, where the coffee culture is thriving, there’s a special charm to be found in visiting small, locally-owned coffee shops. One such gem is Little Lingonberry, a cozy spot that captures
Qure.ai Launches FDA-cleared AI Solution for Advanced Lung Nodule Quantification on CT Scans at AABIP 2024
Qure.ai reports the new AI solution is now available to support radiologists and pulmonologists in analyzing lung nodules on non-contrast chest CT scans and tracking volumetric growth as part of progression monitoring.
MAUI Imaging Emerges From Stealth With $4 Million Department of Defense Contract To Support Trauma Medicine
MAUI Imaging CEO and co-founder David Specht. “The feedback we have received from physicians and technologists highlights the profound need for a new ultrasound-based technology that enables imaging of all types of tissues. That need
PCI Pharma Services In Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
The new ICMRA program is designed to abbreviate the time necessary to receive regulatory approvals from multiple countries. Regulatory agencies from several countries can convene for one inspection as a team, allowing CDMOs such as
Partillion Bioscience Announces Early Access Program for Nanovial Multicell Assays to Enable the Study of Cell-to-Cell Interactions
"Our Nanovial Multicell Assays are a game-changer, opening up new possibilities in research areas where the precise colocalization of cells is essential for studying complex cell-to-cell interactions or screening for therapeutic molecules released by one
XII Medical Raises $45 Mil in Series B Financing
To advance best-in-class neuromodulation therapy for obstructive sleep apnea.
Lucid Diagnostics Announces Publication of Analytical Validation Study of EsoGuard® for Early Detection of Esophageal Precancer and Cancer
"This analytical validation study strongly complements EsoGuard's extensive peer-reviewed, published clinical validity and clinical utility evidence base," said Suman Verma, M.D., PhD, Chief Scientific Officer at Lucid Diagnostics. "The results demonstrate very robust analytical performance
Vantedge Medical Completes Acquisition of Hobson & Motzer
The acquisition of Hobson further strengthens Vantedge's position as a nationwide manufacturing partner to blue-chip medical OEMs and broadens Vantedge's consumable portfolio offering. Since Aterian's acquisition of Vantedge in May 2018, Vantedge has acquired five
Life Molecular Imaging and PharmaLogic announce Neuraceq® availability in Denver
"By partnering with PharmaLogic and offering Neuraceq® in Denver, Life Molecular Imaging is excited to expand access of Neuraceq® for the detection of beta-amyloid plaques in the brain. We believe this additional access benefits physicians



